BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV
CHARLOTTESVILLE, VA – JULY 28, 2025 – RIVANNA®, developers of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS).
With the execution, this option funding will support the development of an advanced AI module designed to automate the detection of anatomical abnormalities and assist in the diagnosis of bone fractures. The total BARDA funding awarded to date under this contract exceeds $52 million, with the potential for cumulative support to reach more than $91 million if all remaining options are exercised.
